Recent Advances in Novel Drug Carrier Systems 2012
DOI: 10.5772/50486
|View full text |Cite
|
Sign up to set email alerts
|

Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
41
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(42 citation statements)
references
References 85 publications
1
41
0
Order By: Relevance
“…SLNs are aqueous colloidal dispersions of which the matrix consists of solidified lipids that are highly structured [67] ( Figure 4). The disadvantages are their particle growth is not always controllable, their unpredictable gelation tendency, their unexpected dynamics of polymorphic transitions, and their inherent low incorporation rate due to the crystalline structure of the solid lipid [69,70]. The particles are prepared either with physiological lipids, or with lipids generally recognised as safe (GRAS).…”
Section: Solid Lipid Nanoparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…SLNs are aqueous colloidal dispersions of which the matrix consists of solidified lipids that are highly structured [67] ( Figure 4). The disadvantages are their particle growth is not always controllable, their unpredictable gelation tendency, their unexpected dynamics of polymorphic transitions, and their inherent low incorporation rate due to the crystalline structure of the solid lipid [69,70]. The particles are prepared either with physiological lipids, or with lipids generally recognised as safe (GRAS).…”
Section: Solid Lipid Nanoparticlesmentioning
confidence: 99%
“…The bilayers are separated from one another by aqueous domains and they enclose an aqueous core. Particle sizes of liposomes for these applications typically range from 25 nm up to several lm and are usually dispersed in an aqueous medium [70,77]. Hydrophobic ingredients will be entrapped in the double layer of the liposomes, whereas hydrophilic ingredients will be entrapped in the aqueous core of the liposome (see Figure 4).…”
Section: Liposomesmentioning
confidence: 99%
“…Furthermore, these carriers are well-accepted in the scientific community for therapeutic purposes mainly because its structural units are generally recognized as safe (GRAS) [25]. Additionally, lipids biocompatibility and biodegradability properties as well as their versatility makes them suitable and safe delivery systems for humans, with low or non-associated toxicity [11,26]. The large number of lipid-based nanocarriers developed for ARV delivery justifies a constant updated review.…”
Section: Introductionmentioning
confidence: 99%
“…Lipid nanoparticles systems (LNs) which have to generation's first, solid lipid nanoparticles (SLN) and second, nanostructured lipid carrier (NLCs) can improve the lymphatic transport of the lipophilic drugs as CC and hence, increase its oral bioavailability 4 . LNs systems were recorded as an advanced drug carrier system than polymeric nanoparticles 5,6 . Advantages of nanostructured lipid carriers (NLCs) over the advantages of polymeric nanoparticles because of the lipid component matrix and its properties, which is physiologically tolerated.…”
Section: Introductionmentioning
confidence: 99%